Back to Newsroom

Arbutus to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference

VANCOUVER, British Columbia and WARMINSTER, Pa., Sept. 25, 2017 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation(Nasdaq:ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, announced today that the company will present a corporate overview and business update at the 2017 Cantor Fitzgerald Global Healthcare Conference on Wednesday, September 27, 2017 in New York.